false
OasisLMS
Catalog
SCCM Resource Library
Solace and Survival: Updates in PAD/Palliative Car ...
Solace and Survival: Updates in PAD/Palliative Care
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses updates on sedation strategies and delirium management in COVID-19 patients. It highlights that COVID-19 ARDS patients require more sedation and have a higher need for IV benzodiazepines. In the case of drug shortages, inhaled anesthetics can be an alternative option. Light sedation in COVID-19 patients leads to better outcomes, such as shorter ventilation and ICU days, and lower mortality rate. However, adherence to sedation guidelines may have decreased during the COVID-19 pandemic. A study on IV haloperidol for ICU delirium management shows no improvement in survival or delirium.
Asset Subtitle
Ethics End of Life, 2023
Asset Caption
Type: year in review | Year in Review: Clinical Pharmacy and Pharmacology (SessionID 2000002)
Meta Tag
Content Type
Presentation
Knowledge Area
Ethics End of Life
Learning Pathway
Delirium and Sedation Managment
Membership Level
Professional
Membership Level
Select
Tag
Palliative Care
Year
2023
Keywords
sedation strategies
delirium management
COVID-19 patients
IV benzodiazepines
inhaled anesthetics
×
Please select your language
1
English